No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19

No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19

The relation between pre-vaccination antipyretic use and antibody responses to SARS-CoV-2 vaccination has been unclear. We measured the pre- and post-BNT162b2 booster spike-specific IgG titers and recorded antipyretic use and adverse reactions for SARS-CoV-2-naive hospital healthcare workers. The da...

Full description

Bibliographic Details
Main Authors: Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Yuki Yanagihara, Yasuo Kurata, Ryo Oishi, Junya Minami, Kyoko Onozawa, Sukehisa Nagano, Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Vaccine: X
Subjects:
Antipyretic
SARS-CoV-2
Vaccine
Antibody
Reactogenicity
Booster
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136222000845

Similar Items

Similar Items